Metraipolis › archive › dc_e2dac4b59465

SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memory — Europe PMC PMID:41715215

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41715215
DOI
10.1186/s13027-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-05T15:37:04.495Z
SHA-256 of the archived text
a79eddecb83bb0869736c195a4e59b3e8fb98eaacac11d74f09755c7b70f8c16
Stable URL of this page
https://metraipolis.com/documento/dc_e2dac4b59465

How to cite

SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memory — Europe PMC PMID:41715215 — Europe PMC (en), https://europepmc.org/article/MED/41715215 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2dac4b59465 (Metraipolis archive dc_e2dac4b59465, sha256 a79eddecb83bb0869736c195a4e59b3e8fb98eaacac11d74f09755c7b70f8c16)
BibTeX
@misc{dce2dac4b59465,
  title = {SOX9 and TNFAIP3 dysregulation in HCV-associated HCC after DAA therapy: insights into post-viral oncogenic memory — Europe PMC PMID:41715215},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41715215},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2dac4b59465; sha256 a79eddecb83bb0869736c195a4e59b3e8fb98eaacac11d74f09755c7b70f8c16},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41715215. Agents can read the archived copy with the MCP tool read_document.